Skip to main content
. 2022 Dec 23;2022:8996203. doi: 10.1155/2022/8996203

Figure 1.

Figure 1

Sequential treatment with activin and hepatocyte growth factor (HGF) promotes cell migration and invasion in vitro and liver metastases in vivo. (a–b) Transwell assays demonstrate that sequential treatment with activin and HGF increases the migration and invasion abilities of HCT116 cells. (c) Wound-healing assays show that sequential treatment with activin and HGF enhances the wound-healing capacity of HCT116 cells. (d) Sequential treatment with activin and HGF promotes liver metastases in nude mice. ∗P < 0.05.